JAZZ PHARMACEUTICALS PLC (JAZZ)
IE00B4Q5ZN47 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 797.58M | 437.72M | 334.00M | 511.00M | 517.00M | |||
| Cash Equivalents | 1.42B | 1.07B | 517.00M | N/A | N/A | |||
| Marketable Securities | 400.00M | 120.00M | 30.00M | 81.00M | 1.62B | |||
| Receivables | 723.64M | 855.10M | 743.00M | 563.00M | 396.00M | |||
| Inventories | 539.30M | 597.04M | 714.00M | 1.07B | 95.00M | |||
| Other Current Assets | 509.35M | 356.98M | 268.00M | 383.00M | 214.00M | |||
| Total Current Assets | 4.39B | 3.44B | 2.61B | 2.61B | 2.84B | |||
| Non-Current Assets | ||||||||
| PPE Net | 253.59M | 234.99M | 301.00M | 343.00M | 257.00M | |||
| Goodwill | 1.80B | 1.75B | 1.69B | 1.83B | 958.00M | |||
| Intangibles | 5.14B | 5.42B | 5.79B | 7.15B | 2.19B | |||
| Other Non-Current Assets | 662.84M | 551.78M | 441.00M | 364.00M | 286.00M | |||
| Total Non-Current Assets | 7.87B | 7.96B | 8.23B | 9.69B | 3.70B | |||
| TOTAL ASSETS | 12.26B | 11.39B | 10.84B | 12.30B | 6.54B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 31.00M | 605.38M | 31.00M | 31.00M | 246.00M | |||
| Accrued Expenses | 858.01M | 792.80M | 803.00M | 647.00M | 349.00M | |||
| Accounts Payable | 85.42M | 102.75M | 91.00M | 100.00M | 27.00M | |||
| Other Current Liabilities | 55.55M | 35.76M | 8.00M | 30.00M | 31.00M | |||
| Total Current Liabilities | 1.03B | 1.54B | 933.00M | 809.00M | 654.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.08B | 5.11B | 5.70B | 6.03B | 1.85B | |||
| Deferred Taxes/Income | 791.78M | 847.71M | 944.00M | 1.30B | 130.00M | |||
| Other Non-Current Liabilities | 182.09M | 158.94M | 173.00M | 198.00M | 243.00M | |||
| Total Non-Current Liabilities | 7.05B | 6.12B | 6.82B | 7.52B | 2.22B | |||
| TOTAL LIABILITIES | 8.08B | 7.66B | 7.75B | 8.33B | 2.88B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 936.71M | 879.13M | 734.00M | 831.00M | 1.16B | |||
| Additional Paid In Capital | 3.84B | 3.70B | 3.48B | 3.54B | 2.63B | |||
| Common Shares | 61.00K | 61.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -603.40M | -842.15M | -1.13B | -400.00M | -134.00M | |||
| Shares Outstanding | 60.44M | 62.26M | 63.00M | 62.00M | 56.00M | |||
| Tangible Book Value per Share | -45.96 | -55.16 | -69.86 | -80.89 | 9.05 | |||
| Total Shareholders' Equity | 4.17B | 3.74B | 3.09B | 3.96B | 3.66B | |||
| TOTAL LIABILITIES AND EQUITY | 12.26B | 11.39B | 10.84B | 12.30B | 6.54B | |||
| Statistics | ||||||||
| Debt/Equity | 1.46 | 1.37 | 1.85 | 1.52 | 0.51 | |||
| Current Ratio | 4.26 | 2.24 | 2.79 | 3.23 | 4.34 | |||
| Return On Assets (ROA) | 3.78% | 3.64% | -2.07% | -2.68% | 3.65% | |||
| Return On Equity (ROE) | 11.10% | 11.10% | -7.26% | -8.32% | 6.52% | |||
| Return On Invested Capital (ROIC) | 4.95% | 5.44% | 0.87% | 2.75% | 6.91% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 5.91% | 6.18% | 0.92% | 2.76% | 9.52% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 22.63% | 35.80% | 4.61% | 12.99% | 36.50% | |||
All data in USD , ROIC based on taxRate of 0.21